启迪药业 (000590.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(启迪药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 77,093,552.53404,647,908.22274,629,835.65190,050,700.64101,199,883.45350,528,110.13371,821,645.67178,391,627.3992,417,774.85
 营业利润(元) -7,020,708.1720,159,699.669,493,975.958,984,099.358,275,180.5822,672,907.8420,142,944.3814,162,336.7514,824,181.88
 利润总额(元) -7,068,959.3829,679,239.999,491,775.508,994,108.428,274,305.7021,876,050.2320,148,905.5314,160,281.7014,823,532.75
 净利润(元) -8,266,488.5824,890,199.756,577,260.146,457,016.146,608,510.6118,172,535.7415,823,154.6911,582,235.7912,450,763.04
 归属于母公司股东的净利润(元) -8,284,339.2825,246,778.766,430,149.786,382,540.846,584,800.3918,145,855.1415,699,130.1611,554,184.5512,501,913.58
盈利能力:
 销售毛利率(%) 50.7752.4252.5953.5753.2851.1232.6845.3352.28
 销售净利率(%) -10.726.152.403.406.535.184.266.4913.47
 净资产收益率(%) -1.173.550.920.910.94----
 总资产报酬率ROA(%) -0.562.740.980.960.81----
 投入资本回报率ROIC(%) -0.972.980.770.760.782.372.211.651.79
营运能力:
 存货周转率(次) 0.271.551.100.850.43----
 应收账款周转率(次) 4.3917.6214.4122.119.97----
 总资产周转率(次) 0.070.350.240.180.10----
偿债能力:
 资产负债率(%) 38.0936.7436.5636.9538.9239.7938.6427.8227.68
 股东权益比率(%) 61.4962.8763.0862.7060.7459.8661.0071.8171.96
 已获利息倍数(倍) -11.8515.097.179.8327.82-5.07-5.57-6.37-11.04
 流动比率 2.082.172.242.232.041.951.533.303.30
 速动比率 1.501.611.651.641.501.491.102.652.59
发展能力:
 营业收入增长率(%) -23.8215.4416.1022.3510.7616.5471.8120.1220.43
 营业利润增长率(%) -184.84-11.08-52.87-36.56-44.18-46.47-55.52-57.95-31.19
 税后利润增长率(%) -225.8139.41-59.04-44.76-47.33-48.80-59.81-60.43-38.90
 净资产增长率(%) 1.473.611.281.881.772.671.772.644.13
 总资产增长率(%) 0.23-1.36-2.0716.6820.5820.5523.905.674.55

前瞻产业研究院